Al-Hasso IKQ. Evaluation of Interleukin-22 and Toll-like receptor-2 as an Immunological Biomarkers in Breast Cancer Patients. Al-Kindy Col. Med. J. 2024;20(2):97-100. doi:10.47723/3sfb2q82